Application of Fluevirosines A in preparation of anti-platelet aggregation drug

An anti-platelet aggregation and drug technology, applied in the direction of drug combination, blood diseases, pharmaceutical formulations, etc., can solve urgent problems, minor adverse reactions, etc.

Inactive Publication Date: 2013-12-18
QINGDAO MUNICIPAL HOSPITAL
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently commonly used antiplatelet drugs have severe adverse reactions, so it is urgent to develo...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Fluevirosines A in preparation of anti-platelet aggregation drug
  • Application of Fluevirosines A in preparation of anti-platelet aggregation drug
  • Application of Fluevirosines A in preparation of anti-platelet aggregation drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0011] Embodiment 1: the preparation of the compound Fluevirosines A tablet involved in the present invention:

[0012] Take 5 grams of compound Fluevirosines A, add 195 grams of dextrin, mix well, and make 1000 tablets by conventional compression.

Embodiment 2

[0013] Embodiment 2: the preparation of compound Fluevirosines A capsules involved in the present invention:

[0014] Get 5 grams of compound Fluevirosines A, add 195 grams of starch, mix well, and pack into capsules to make 1000 capsules.

[0015] The following pharmacodynamic experiments will further illustrate its drug activity.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to application of Fluevirosines A in preparation of an anti-platelet aggregation drug. The application of the Fluevirosines A in the preparation of the anti-platelet aggregation drug is disclosed for the first time. Due to the fact that the skeleton type is a novel skeleton type, the Fluevirosines A has outstanding substantive characteristics and meanwhile has a remarkable improvement in platelet aggregation inhibition obviously.

Description

technical field [0001] The present invention relates to the new application of compound Fluevirosines A, in particular to the application of Fluevirosines A in the preparation of anti-platelet aggregation drugs. Background technique [0002] As a formed component of blood, platelets play a very important role in the process of physiological hemostasis and pathological thrombus formation. Clinical studies have shown that common cardiovascular and cerebrovascular diseases such as hypertension, angina pectoris, myocardial infarction, cerebral infarction and cerebral hemorrhage are basically related to changes in platelet function and abnormal hemorheology. Currently commonly used antiplatelet drugs have severe adverse reactions, so it is urgent to develop new effective drugs for the treatment and prevention of platelet aggregation with less adverse reactions. Through experimental research, the inventors found that Fluevirosines A has the effect of anti-platelet aggregation. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/407A61P7/02
Inventor 高忠青
Owner QINGDAO MUNICIPAL HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap